List of Excipients in API insulin glargine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing insulin glargine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | GLYCERIN | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | METACRESOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for insulin glargine
Excipient focus: AQUA
insulin glargine drug variants containing AQUA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | insulin glargine | 50090-6184 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing AQUA
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
insulin glargine drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
insulin glargine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| sanofi-aventis US LLC | insulin glargine | 0088-5021 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| A-S Medication Solutions | insulin glargine | 50090-2193 |
| A-S Medication Solutions | insulin glargine | 50090-4177 |
| >Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
insulin glargine drug variants containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
insulin glargine drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
insulin glargine drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| sanofi-aventis US LLC | insulin glargine | 0088-5021 |
| Winthrop US | insulin glargine | 0955-1729 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| Winthrop US | insulin glargine | 0955-3900 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
insulin glargine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| sanofi-aventis US LLC | insulin glargine | 0088-5021 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| A-S Medication Solutions | insulin glargine | 50090-2193 |
| A-S Medication Solutions | insulin glargine | 50090-4177 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
insulin glargine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | insulin glargine | 50090-6184 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC
insulin glargine drug variants containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| sanofi-aventis US LLC | insulin glargine | 0088-5021 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
| Eli Lilly and Company | insulin glargine-aglr | 0002-8980 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC CHLORIDE
insulin glargine drug variants containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
| Mylan Specialty LP | insulin glargine-yfgn | 49502-251 |
| Mylan Specialty LP | insulin glargine-yfgn | 49502-394 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC OXIDE
insulin glargine drug variants containing ZINC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| Eli Lilly and Company | insulin glargine-aglr | 0002-8980 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing ZINC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| sanofi-aventis US LLC | insulin glargine | 0088-2220 |
| sanofi-aventis US LLC | insulin glargine | 0088-5021 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
